Contrave (Mysimba EU)
Naltrexone/Bupropion
Contrave (naltrexone/bupropion) is an oral, centrally acting combination medication approved for chronic weight management in adults with obesity or overweight plus a related comorbidity. It targets appetite and reward pathways in the brain, helping reduce food cravings and emotional eating. By combining an opioid antagonist (naltrexone) with an antidepressant/smoking-cessation aid (bupropion), Contrave influences both hunger signals and hedonic eating behavior. When paired with a reduced-calorie diet and increased physical activity, it can facilitate moderate, sustained weight loss. It’s particularly useful for patients whose eating behavior is influenced by cravings or reward-driven eating rather than solely physiological hunger.
- Manufacturer: Currax/Orexigen
- Primary Use: Chronic Weight Management
- Form: Oral
Common Side Effects
The most common side effects of Contrave (Mysimba EU) may include:
- Nausea
- Headache
- Constipation
- Dizziness
- Insomnia
This is not a complete list. Always consult with your healthcare provider about potential side effects.
Medical Disclaimer
The information provided for Contrave (Mysimba EU) is for informational purposes only and is not a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or treatment. Read our full disclaimer.